Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 8.19947292 |
2 | positive regulation of chemokine secretion (GO:0090197) | 7.55054523 |
3 | regulation of chemokine secretion (GO:0090196) | 6.50195458 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.15085166 |
5 | T cell migration (GO:0072678) | 6.12056493 |
6 | cellular response to interleukin-15 (GO:0071350) | 6.05573922 |
7 | negative thymic T cell selection (GO:0045060) | 5.65112439 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.60255213 |
9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.60255213 |
10 | response to interleukin-15 (GO:0070672) | 5.54373070 |
11 | negative T cell selection (GO:0043383) | 5.52661258 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42089590 |
13 | leukocyte aggregation (GO:0070486) | 5.26097098 |
14 | positive thymic T cell selection (GO:0045059) | 5.00964348 |
15 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.76487688 |
16 | positive regulation of macrophage activation (GO:0043032) | 4.76327866 |
17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.64356078 |
18 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 4.53557503 |
19 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.48306500 |
20 | Peyers patch development (GO:0048541) | 4.48306500 |
21 | interferon-gamma production (GO:0032609) | 4.42420076 |
22 | cellular extravasation (GO:0045123) | 4.42155827 |
23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.27925044 |
24 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.21775210 |
25 | regulation of interleukin-5 production (GO:0032674) | 4.21204780 |
26 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.19673728 |
27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.19211316 |
28 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.19211316 |
29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.18300629 |
30 | NIK/NF-kappaB signaling (GO:0038061) | 4.17938547 |
31 | thymic T cell selection (GO:0045061) | 4.16155004 |
32 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.15513863 |
33 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.15513863 |
34 | regulation of gonadotropin secretion (GO:0032276) | 4.10130365 |
35 | negative regulation of adaptive immune response (GO:0002820) | 4.09855668 |
36 | positive regulation of antigen processing and presentation (GO:0002579) | 4.03792555 |
37 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.03183145 |
38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.02294774 |
39 | myeloid dendritic cell differentiation (GO:0043011) | 3.99018603 |
40 | positive T cell selection (GO:0043368) | 3.97484730 |
41 | negative regulation of cell killing (GO:0031342) | 3.95608830 |
42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95608830 |
43 | positive regulation of macrophage differentiation (GO:0045651) | 3.95014252 |
44 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.92971880 |
45 | microglial cell activation (GO:0001774) | 3.90994009 |
46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.90989301 |
47 | myeloid dendritic cell activation (GO:0001773) | 3.90636091 |
48 | tolerance induction (GO:0002507) | 3.89541100 |
49 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.89176331 |
50 | hepatocyte apoptotic process (GO:0097284) | 3.87132418 |
51 | cellular response to type I interferon (GO:0071357) | 3.86728414 |
52 | type I interferon signaling pathway (GO:0060337) | 3.86728414 |
53 | response to type I interferon (GO:0034340) | 3.86334004 |
54 | sequestering of actin monomers (GO:0042989) | 3.86222494 |
55 | negative regulation of macrophage differentiation (GO:0045650) | 3.81958728 |
56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.80633453 |
57 | regulation of T-helper 1 type immune response (GO:0002825) | 3.80370317 |
58 | lymphocyte migration (GO:0072676) | 3.79804630 |
59 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.79311671 |
60 | regulation of activation of Janus kinase activity (GO:0010533) | 3.77842408 |
61 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.76771887 |
62 | hemoglobin metabolic process (GO:0020027) | 3.76754766 |
63 | regulation of cell killing (GO:0031341) | 3.76309940 |
64 | macrophage activation involved in immune response (GO:0002281) | 3.72802959 |
65 | detection of molecule of bacterial origin (GO:0032490) | 3.72237001 |
66 | T cell costimulation (GO:0031295) | 3.71035314 |
67 | positive regulation of cell killing (GO:0031343) | 3.70538510 |
68 | regulation of memory T cell differentiation (GO:0043380) | 3.70120325 |
69 | positive regulation of defense response to virus by host (GO:0002230) | 3.70033111 |
70 | lymphocyte costimulation (GO:0031294) | 3.67698875 |
71 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.67570627 |
72 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67316594 |
73 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67316594 |
74 | modulation by symbiont of host immune response (GO:0052553) | 3.67316594 |
75 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67316594 |
76 | modulation by symbiont of host defense response (GO:0052031) | 3.67316594 |
77 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67316594 |
78 | neutrophil activation involved in immune response (GO:0002283) | 3.66248693 |
79 | DNA deamination (GO:0045006) | 3.65980244 |
80 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.63319885 |
81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.61440933 |
82 | T cell selection (GO:0045058) | 3.60734776 |
83 | negative regulation of interferon-gamma production (GO:0032689) | 3.55247505 |
84 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.51595662 |
85 | regulation of antigen processing and presentation (GO:0002577) | 3.46004951 |
86 | lymphocyte chemotaxis (GO:0048247) | 3.44223881 |
87 | daunorubicin metabolic process (GO:0044597) | 3.43824802 |
88 | polyketide metabolic process (GO:0030638) | 3.43824802 |
89 | doxorubicin metabolic process (GO:0044598) | 3.43824802 |
90 | regulation of response to interferon-gamma (GO:0060330) | 3.42484560 |
91 | T-helper cell differentiation (GO:0042093) | 3.39811790 |
92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.39811790 |
93 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.37863007 |
94 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.37863007 |
95 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.37863007 |
96 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.35929280 |
97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35347698 |
98 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.34991906 |
99 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.33745380 |
100 | regulation of RIG-I signaling pathway (GO:0039535) | 3.29747631 |
101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29330342 |
102 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.25301028 |
103 | negative regulation of interleukin-10 production (GO:0032693) | 3.23331078 |
104 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.23066491 |
105 | positive regulation of neutrophil migration (GO:1902624) | 3.23066491 |
106 | regulation of regulatory T cell differentiation (GO:0045589) | 3.21402752 |
107 | macrophage activation (GO:0042116) | 3.20566220 |
108 | regulation of natural killer cell differentiation (GO:0032823) | 3.18735514 |
109 | lymph node development (GO:0048535) | 3.18677945 |
110 | regulation of B cell differentiation (GO:0045577) | 3.18472259 |
111 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.17737388 |
112 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17503879 |
113 | neutrophil mediated immunity (GO:0002446) | 3.16953387 |
114 | leukocyte cell-cell adhesion (GO:0007159) | 3.14843638 |
115 | positive regulation of T cell differentiation (GO:0045582) | 3.14710207 |
116 | negative regulation of interleukin-12 production (GO:0032695) | 3.14009375 |
117 | natural killer cell activation (GO:0030101) | 3.13725804 |
118 | positive regulation of mast cell activation (GO:0033005) | 3.12490183 |
119 | regulation of mast cell activation (GO:0033003) | 3.12485692 |
120 | T cell receptor signaling pathway (GO:0050852) | 3.12405437 |
121 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.11512695 |
122 | cellular defense response (GO:0006968) | 3.11344531 |
123 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10976153 |
124 | mature B cell differentiation involved in immune response (GO:0002313) | 3.10168689 |
125 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.09822202 |
126 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.09242575 |
127 | dendritic cell differentiation (GO:0097028) | 3.08773942 |
128 | regulation of endothelial cell differentiation (GO:0045601) | 3.03990964 |
129 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.03748599 |
130 | dendritic cell chemotaxis (GO:0002407) | 3.01161002 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00083643 |
132 | T cell differentiation involved in immune response (GO:0002292) | 2.98280308 |
133 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.98280308 |
134 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97424026 |
135 | detection of other organism (GO:0098543) | 2.95333049 |
136 | detection of external biotic stimulus (GO:0098581) | 2.94234922 |
137 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.92855637 |
138 | neutrophil activation (GO:0042119) | 2.91699980 |
139 | regulation of macrophage differentiation (GO:0045649) | 2.88551381 |
140 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.87349886 |
141 | myeloid cell activation involved in immune response (GO:0002275) | 2.84394780 |
142 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.73421007 |
143 | positive regulation of tyrosine phosphorylation of Stat3 protein (GO:0042517) | 2.73313536 |
144 | cellular response to sterol (GO:0036315) | 2.73298933 |
145 | response to peptidoglycan (GO:0032494) | 2.72561996 |
146 | positive regulation of chemokine production (GO:0032722) | 2.72115170 |
147 | positive regulation of granulocyte differentiation (GO:0030854) | 2.72011131 |
148 | negative regulation of complement activation (GO:0045916) | 2.71382941 |
149 | myeloid leukocyte mediated immunity (GO:0002444) | 2.70880841 |
150 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70103650 |
151 | regulation of macrophage activation (GO:0043030) | 2.68036904 |
152 | detection of biotic stimulus (GO:0009595) | 2.68024033 |
153 | B cell receptor signaling pathway (GO:0050853) | 2.67896302 |
154 | establishment of protein localization to Golgi (GO:0072600) | 2.67798983 |
155 | response to host immune response (GO:0052572) | 2.67374274 |
156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67374274 |
157 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.66436885 |
158 | negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124) | 2.65958804 |
159 | definitive hemopoiesis (GO:0060216) | 2.64741911 |
160 | dendritic cell migration (GO:0036336) | 2.64599683 |
161 | cellular response to ethanol (GO:0071361) | 2.63639361 |
162 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.63450505 |
163 | negative regulation of B cell activation (GO:0050869) | 2.61115468 |
164 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61042744 |
165 | positive regulation of mast cell degranulation (GO:0043306) | 2.61042744 |
166 | regulation of mast cell degranulation (GO:0043304) | 2.60486929 |
167 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56449174 |
168 | response to follicle-stimulating hormone (GO:0032354) | 2.56185045 |
169 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56017444 |
170 | regulation of tolerance induction (GO:0002643) | 2.55361352 |
171 | protein targeting to Golgi (GO:0000042) | 2.53959424 |
172 | detection of bacterium (GO:0016045) | 2.53547750 |
173 | endocrine hormone secretion (GO:0060986) | 2.52595062 |
174 | histamine secretion (GO:0001821) | 2.52379713 |
175 | cell wall macromolecule catabolic process (GO:0016998) | 2.49354072 |
176 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.48673162 |
177 | amine catabolic process (GO:0009310) | 2.47789551 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.52577606 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.41148836 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.69123053 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.74845567 |
5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.74751722 |
6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.07448154 |
7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.05758834 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.87186171 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.69172721 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38301211 |
11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.99844658 |
12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.90360512 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86246190 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.80479193 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.79665685 |
16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.68034608 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57360509 |
18 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.57192255 |
19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.51298430 |
20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46212900 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28881471 |
22 | MYB_26560356_Chip-Seq_TH1_Human | 2.27885365 |
23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.27390311 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.24473885 |
25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22164024 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20719636 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17603102 |
28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08034644 |
29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03153283 |
30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.97625869 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96713052 |
32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95381874 |
33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.95295213 |
34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92328737 |
35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.88148760 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86433555 |
37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79800450 |
38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78267782 |
39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77986596 |
40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.76187384 |
41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74703347 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74598927 |
43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73659796 |
44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73175631 |
45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72757610 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72629831 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69725332 |
48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68633716 |
49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66204665 |
50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64656168 |
51 | MYC_22102868_ChIP-Seq_BL_Human | 1.64482178 |
52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58050594 |
53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57370063 |
54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56482439 |
55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53456861 |
56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51750204 |
57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51406554 |
58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50435578 |
59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48535712 |
60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47088501 |
61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45074883 |
62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44553511 |
63 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43231396 |
64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43199486 |
65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41032915 |
66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40639838 |
67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39405757 |
68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38779491 |
69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35742792 |
70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31219184 |
71 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31184553 |
72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27767430 |
73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26227367 |
74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25945011 |
75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25609322 |
76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25519977 |
77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23164909 |
78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22633981 |
79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22479577 |
80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22320695 |
81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20194336 |
82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19724691 |
83 | MAF_26560356_Chip-Seq_TH2_Human | 1.18755090 |
84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18735895 |
85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18611090 |
86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17297746 |
87 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17292856 |
88 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17231259 |
89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17213476 |
90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15991515 |
91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15820811 |
92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15748648 |
93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14773672 |
94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14307848 |
95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12259967 |
96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11702142 |
97 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11294768 |
98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10700243 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10652726 |
100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10414530 |
101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10251201 |
102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10121884 |
103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08336638 |
104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07277674 |
105 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06957870 |
106 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06514751 |
107 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06341029 |
108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06123684 |
109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05846411 |
110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05397755 |
111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04856368 |
112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04133450 |
113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04129237 |
114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03717621 |
115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03424878 |
116 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03150530 |
117 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.02009761 |
118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01981079 |
119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01966561 |
120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01321971 |
121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01173121 |
122 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00422981 |
123 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.00422981 |
124 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00288009 |
125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99210663 |
126 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.98996849 |
127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98712464 |
128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98541862 |
129 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98445647 |
130 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97281858 |
131 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96456770 |
132 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96123560 |
133 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95448562 |
134 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94591467 |
135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92024861 |
136 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91439187 |
137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89423939 |
138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88820254 |
139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88336021 |
140 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85927195 |
141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85607072 |
142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84606857 |
143 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.84055078 |
144 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.82833344 |
145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80114655 |
146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78490366 |
147 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.78459191 |
148 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77897461 |
149 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76982133 |
150 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76676719 |
151 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74139477 |
152 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72852593 |
153 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.71555052 |
154 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.71435624 |
155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69960505 |
156 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69636571 |
157 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.67644161 |
158 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66948519 |
159 | P300_27268052_Chip-Seq_Bcells_Human | 0.65398626 |
160 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63588028 |
161 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62944470 |
162 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.61417550 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 5.05911792 |
2 | MP0000685_abnormal_immune_system | 4.60755116 |
3 | MP0002254_reproductive_system_inflammat | 4.20625057 |
4 | MP0001835_abnormal_antigen_presentation | 4.15318787 |
5 | MP0009785_altered_susceptibility_to | 3.95261810 |
6 | MP0003763_abnormal_thymus_physiology | 3.93435258 |
7 | MP0003724_increased_susceptibility_to | 3.71781190 |
8 | MP0006082_CNS_inflammation | 3.43013776 |
9 | MP0001873_stomach_inflammation | 2.91550893 |
10 | MP0000569_abnormal_digit_pigmentation | 2.89465939 |
11 | MP0001800_abnormal_humoral_immune | 2.82429738 |
12 | MP0005670_abnormal_white_adipose | 2.79758253 |
13 | MP0005000_abnormal_immune_tolerance | 2.71109934 |
14 | MP0001790_abnormal_immune_system | 2.70788094 |
15 | MP0005387_immune_system_phenotype | 2.70788094 |
16 | MP0005025_abnormal_response_to | 2.69199590 |
17 | MP0002723_abnormal_immune_serum | 2.53323206 |
18 | MP0005171_absent_coat_pigmentation | 2.49585216 |
19 | MP0002405_respiratory_system_inflammati | 2.47774363 |
20 | MP0004510_myositis | 2.45562502 |
21 | MP0002420_abnormal_adaptive_immunity | 2.41333103 |
22 | MP0001819_abnormal_immune_cell | 2.40529446 |
23 | MP0005187_abnormal_penis_morphology | 2.35582895 |
24 | MP0002452_abnormal_antigen_presenting | 2.34418860 |
25 | MP0003787_abnormal_imprinting | 2.34248305 |
26 | MP0003136_yellow_coat_color | 2.31406473 |
27 | MP0002166_altered_tumor_susceptibility | 2.19212568 |
28 | MP0005310_abnormal_salivary_gland | 2.18524261 |
29 | MP0000015_abnormal_ear_pigmentation | 2.15508532 |
30 | MP0002398_abnormal_bone_marrow | 2.14714318 |
31 | MP0009333_abnormal_splenocyte_physiolog | 2.13189075 |
32 | MP0010155_abnormal_intestine_physiology | 2.12081000 |
33 | MP0003436_decreased_susceptibility_to | 2.11198121 |
34 | MP0008877_abnormal_DNA_methylation | 2.08087585 |
35 | MP0000716_abnormal_immune_system | 2.02139085 |
36 | MP0005464_abnormal_platelet_physiology | 1.93852873 |
37 | MP0003172_abnormal_lysosome_physiology | 1.91047315 |
38 | MP0002419_abnormal_innate_immunity | 1.90446794 |
39 | * MP0002148_abnormal_hypersensitivity_rea | 1.87450425 |
40 | MP0003045_fibrosis | 1.85535862 |
41 | MP0001348_abnormal_lacrimal_gland | 1.79561162 |
42 | MP0002722_abnormal_immune_system | 1.76695126 |
43 | MP0002006_tumorigenesis | 1.76379315 |
44 | MP0001845_abnormal_inflammatory_respons | 1.74431296 |
45 | MP0000703_abnormal_thymus_morphology | 1.70520418 |
46 | MP0003448_altered_tumor_morphology | 1.61203572 |
47 | MP0002429_abnormal_blood_cell | 1.59525663 |
48 | MP0003866_abnormal_defecation | 1.59366039 |
49 | MP0002876_abnormal_thyroid_physiology | 1.58664410 |
50 | MP0000689_abnormal_spleen_morphology | 1.53728582 |
51 | MP0002933_joint_inflammation | 1.52891201 |
52 | MP0003300_gastrointestinal_ulcer | 1.50063194 |
53 | MP0004947_skin_inflammation | 1.49986178 |
54 | MP0001853_heart_inflammation | 1.42588888 |
55 | MP0001346_abnormal_lacrimal_gland | 1.40989772 |
56 | MP0002396_abnormal_hematopoietic_system | 1.40467883 |
57 | MP0001986_abnormal_taste_sensitivity | 1.30732334 |
58 | MP0008469_abnormal_protein_level | 1.29741121 |
59 | MP0003252_abnormal_bile_duct | 1.26743470 |
60 | MP0001851_eye_inflammation | 1.26332073 |
61 | MP0006054_spinal_hemorrhage | 1.26129256 |
62 | MP0009764_decreased_sensitivity_to | 1.25853030 |
63 | MP0005164_abnormal_response_to | 1.23695486 |
64 | MP0002009_preneoplasia | 1.22312123 |
65 | MP0004883_abnormal_blood_vessel | 1.22309236 |
66 | MP0001533_abnormal_skeleton_physiology | 1.19307103 |
67 | MP0003195_calcinosis | 1.17826245 |
68 | MP0000858_altered_metastatic_potential | 1.11981527 |
69 | MP0002877_abnormal_melanocyte_morpholog | 1.11701545 |
70 | MP0010352_gastrointestinal_tract_polyps | 1.05994161 |
71 | MP0002735_abnormal_chemical_nociception | 1.02438430 |
72 | MP0000371_diluted_coat_color | 1.00495809 |
73 | MP0003303_peritoneal_inflammation | 0.99608181 |
74 | MP0005084_abnormal_gallbladder_morpholo | 0.99366453 |
75 | MP0004484_altered_response_of | 0.99274003 |
76 | MP0009765_abnormal_xenobiotic_induced | 0.98703075 |
77 | MP0002837_dystrophic_cardiac_calcinosis | 0.94962193 |
78 | MP0004808_abnormal_hematopoietic_stem | 0.93279611 |
79 | MP0000465_gastrointestinal_hemorrhage | 0.91757135 |
80 | MP0002928_abnormal_bile_duct | 0.90878730 |
81 | MP0005167_abnormal_blood-brain_barrier | 0.89910332 |
82 | MP0009763_increased_sensitivity_to | 0.89002628 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 0.88573086 |
84 | MP0003183_abnormal_peptide_metabolism | 0.87038155 |
85 | MP0008260_abnormal_autophagy | 0.85764943 |
86 | MP0005645_abnormal_hypothalamus_physiol | 0.84099970 |
87 | MP0002998_abnormal_bone_remodeling | 0.83433254 |
88 | MP0003453_abnormal_keratinocyte_physiol | 0.82626708 |
89 | MP0002019_abnormal_tumor_incidence | 0.81682181 |
90 | MP0003879_abnormal_hair_cell | 0.81403126 |
91 | MP0005408_hypopigmentation | 0.80672577 |
92 | MP0002132_abnormal_respiratory_system | 0.80481345 |
93 | MP0008057_abnormal_DNA_replication | 0.80128785 |
94 | MP0005397_hematopoietic_system_phenotyp | 0.79942980 |
95 | MP0001545_abnormal_hematopoietic_system | 0.79942980 |
96 | MP0005253_abnormal_eye_physiology | 0.78880759 |
97 | MP0004215_abnormal_myocardial_fiber | 0.78269047 |
98 | MP0005165_increased_susceptibility_to | 0.77944657 |
99 | MP0001501_abnormal_sleep_pattern | 0.76991227 |
100 | MP0003638_abnormal_response/metabolism_ | 0.76552889 |
101 | MP0010234_abnormal_vibrissa_follicle | 0.74995716 |
102 | MP0001881_abnormal_mammary_gland | 0.74740567 |
103 | MP0002102_abnormal_ear_morphology | 0.73101546 |
104 | MP0005647_abnormal_sex_gland | 0.72959946 |
105 | MP0000490_abnormal_crypts_of | 0.72381297 |
106 | MP0003075_altered_response_to | 0.71196028 |
107 | MP0004264_abnormal_extraembryonic_tissu | 0.66127835 |
108 | * MP0000343_altered_response_to | 0.65141183 |
109 | MP0005166_decreased_susceptibility_to | 0.64555279 |
110 | MP0002095_abnormal_skin_pigmentation | 0.64273206 |
111 | MP0006072_abnormal_retinal_apoptosis | 0.63611826 |
112 | MP0009278_abnormal_bone_marrow | 0.63428866 |
113 | MP0002138_abnormal_hepatobiliary_system | 0.62687536 |
114 | MP0003690_abnormal_glial_cell | 0.62544766 |
115 | MP0000230_abnormal_systemic_arterial | 0.58645779 |
116 | MP0005023_abnormal_wound_healing | 0.58626297 |
117 | MP0002277_abnormal_respiratory_mucosa | 0.58471252 |
118 | MP0003828_pulmonary_edema | 0.57610309 |
119 | MP0001764_abnormal_homeostasis | 0.54348681 |
120 | MP0001663_abnormal_digestive_system | 0.54020447 |
121 | MP0002136_abnormal_kidney_physiology | 0.53620220 |
122 | MP0005174_abnormal_tail_pigmentation | 0.53001634 |
123 | MP0000249_abnormal_blood_vessel | 0.52956894 |
124 | MP0000604_amyloidosis | 0.51231336 |
125 | MP0004381_abnormal_hair_follicle | 0.51230326 |
126 | MP0009384_cardiac_valve_regurgitation | 0.48941397 |
127 | MP0000372_irregular_coat_pigmentation | 0.48039858 |
128 | MP0001243_abnormal_dermal_layer | 0.47725657 |
129 | MP0008007_abnormal_cellular_replicative | 0.46885740 |
130 | MP0008058_abnormal_DNA_repair | 0.46716324 |
131 | MP0003806_abnormal_nucleotide_metabolis | 0.45441878 |
132 | MP0005075_abnormal_melanosome_morpholog | 0.45366823 |
133 | MP0002693_abnormal_pancreas_physiology | 0.44198334 |
134 | MP0003795_abnormal_bone_structure | 0.43516480 |
135 | MP0005390_skeleton_phenotype | 0.43312080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent cutaneous fungal infections (HP:0011370) | 6.19816177 |
2 | Chronic mucocutaneous candidiasis (HP:0002728) | 6.19816177 |
3 | Eczematoid dermatitis (HP:0000976) | 6.05289877 |
4 | Myositis (HP:0100614) | 5.67665703 |
5 | Severe combined immunodeficiency (HP:0004430) | 5.53325894 |
6 | Recurrent fungal infections (HP:0002841) | 5.40889185 |
7 | Optic neuritis (HP:0100653) | 5.24193343 |
8 | Retrobulbar optic neuritis (HP:0100654) | 5.24193343 |
9 | Keratoconjunctivitis (HP:0001096) | 5.11480639 |
10 | Orchitis (HP:0100796) | 5.01553930 |
11 | Combined immunodeficiency (HP:0005387) | 4.77379262 |
12 | T lymphocytopenia (HP:0005403) | 4.30836846 |
13 | Panhypogammaglobulinemia (HP:0003139) | 4.27493226 |
14 | Abnormality of T cell number (HP:0011839) | 4.26478809 |
15 | Recurrent bronchitis (HP:0002837) | 4.14169885 |
16 | Increased IgE level (HP:0003212) | 4.13771031 |
17 | Abnormality of T cells (HP:0002843) | 4.11004228 |
18 | IgG deficiency (HP:0004315) | 3.94420934 |
19 | Recurrent skin infections (HP:0001581) | 3.93322042 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.89686103 |
21 | Abnormality of T cell physiology (HP:0011840) | 3.88916968 |
22 | Stomatitis (HP:0010280) | 3.88367424 |
23 | Thyroiditis (HP:0100646) | 3.70973171 |
24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65774262 |
25 | Increased IgM level (HP:0003496) | 3.61073252 |
26 | IgM deficiency (HP:0002850) | 3.57402296 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 3.56100995 |
28 | Vasculitis (HP:0002633) | 3.49982912 |
29 | Agammaglobulinemia (HP:0004432) | 3.47839011 |
30 | Recurrent abscess formation (HP:0002722) | 3.35822893 |
31 | Pulmonary infiltrates (HP:0002113) | 3.34886160 |
32 | Nasal polyposis (HP:0100582) | 3.28283914 |
33 | Meningitis (HP:0001287) | 3.27233495 |
34 | Encephalitis (HP:0002383) | 3.19535908 |
35 | Abnormality of eosinophils (HP:0001879) | 3.17583167 |
36 | Hemoptysis (HP:0002105) | 3.16484894 |
37 | Recurrent viral infections (HP:0004429) | 3.15374406 |
38 | Pustule (HP:0200039) | 3.09636568 |
39 | Hypergammaglobulinemia (HP:0010702) | 3.07552223 |
40 | Type 2 muscle fiber atrophy (HP:0003554) | 3.05558354 |
41 | IgA deficiency (HP:0002720) | 3.04114512 |
42 | Inflammation of the large intestine (HP:0002037) | 3.02660743 |
43 | Episodic fever (HP:0001954) | 3.01375833 |
44 | Muscle fiber atrophy (HP:0100295) | 2.99790875 |
45 | Abnormality of the nasal mucosa (HP:0000433) | 2.98732547 |
46 | Stomach cancer (HP:0012126) | 2.97210999 |
47 | Chronic diarrhea (HP:0002028) | 2.96073210 |
48 | Keratitis (HP:0000491) | 2.95225996 |
49 | Recurrent bacterial skin infections (HP:0005406) | 2.93152171 |
50 | Gastrointestinal inflammation (HP:0004386) | 2.89544747 |
51 | Chronic otitis media (HP:0000389) | 2.89038646 |
52 | Joint swelling (HP:0001386) | 2.88887073 |
53 | Thrombocytosis (HP:0001894) | 2.84582074 |
54 | Hematochezia (HP:0002573) | 2.84554318 |
55 | Albinism (HP:0001022) | 2.82201884 |
56 | Hypoplasia of the fovea (HP:0007750) | 2.82025002 |
57 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.82025002 |
58 | Autoimmune hemolytic anemia (HP:0001890) | 2.79246011 |
59 | Arterial thrombosis (HP:0004420) | 2.78235973 |
60 | Lymphopenia (HP:0001888) | 2.76836758 |
61 | Abnormality of macrophages (HP:0004311) | 2.76551611 |
62 | Abnormality of B cell number (HP:0010975) | 2.73688991 |
63 | B lymphocytopenia (HP:0010976) | 2.73688991 |
64 | Chest pain (HP:0100749) | 2.73465070 |
65 | Leukocytosis (HP:0001974) | 2.72046073 |
66 | Gingival bleeding (HP:0000225) | 2.68421116 |
67 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.68122517 |
68 | Ocular albinism (HP:0001107) | 2.65345092 |
69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62593389 |
70 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.61801231 |
71 | Papilledema (HP:0001085) | 2.58263432 |
72 | Autoimmune thrombocytopenia (HP:0001973) | 2.57973069 |
73 | Spontaneous hematomas (HP:0007420) | 2.57313289 |
74 | Gastrointestinal stroma tumor (HP:0100723) | 2.55135165 |
75 | Alveolar cell carcinoma (HP:0006519) | 2.52285307 |
76 | Hepatitis (HP:0012115) | 2.51517534 |
77 | Mediastinal lymphadenopathy (HP:0100721) | 2.48227905 |
78 | Hypoplasia of the thymus (HP:0000778) | 2.46307086 |
79 | Blue irides (HP:0000635) | 2.44894132 |
80 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.44102300 |
81 | Gangrene (HP:0100758) | 2.39558322 |
82 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.39409856 |
83 | Pulmonary embolism (HP:0002204) | 2.38575461 |
84 | Colitis (HP:0002583) | 2.37792659 |
85 | Reduced antithrombin III activity (HP:0001976) | 2.34401688 |
86 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31428956 |
87 | Obstructive lung disease (HP:0006536) | 2.31428956 |
88 | Tubulointerstitial nephritis (HP:0001970) | 2.29380650 |
89 | Hypochromic microcytic anemia (HP:0004840) | 2.27709205 |
90 | Polyneuropathy (HP:0001271) | 2.25073968 |
91 | Prolonged bleeding time (HP:0003010) | 2.23857181 |
92 | Increased CSF protein (HP:0002922) | 2.23298532 |
93 | Generalized hypopigmentation of hair (HP:0011358) | 2.21893735 |
94 | Gingivitis (HP:0000230) | 2.21637891 |
95 | Abnormality of the fovea (HP:0000493) | 2.21111666 |
96 | Interstitial pulmonary disease (HP:0006530) | 2.18226704 |
97 | Asplenia (HP:0001746) | 2.16519188 |
98 | Bronchitis (HP:0012387) | 2.14229608 |
99 | Iris hypopigmentation (HP:0007730) | 2.13830205 |
100 | Epistaxis (HP:0000421) | 2.13038400 |
101 | Vertigo (HP:0002321) | 2.12621168 |
102 | Eosinophilia (HP:0001880) | 2.11666709 |
103 | Lymphoma (HP:0002665) | 2.11634643 |
104 | Granulocytopenia (HP:0001913) | 2.11406619 |
105 | Facial diplegia (HP:0001349) | 2.10832707 |
106 | Hypoalbuminemia (HP:0003073) | 2.10801047 |
107 | Abnormal albumin level (HP:0012116) | 2.10801047 |
108 | Amyloidosis (HP:0011034) | 2.10585910 |
109 | Follicular hyperkeratosis (HP:0007502) | 2.10445341 |
110 | Emphysema (HP:0002097) | 2.10413738 |
111 | Large for gestational age (HP:0001520) | 2.09749180 |
112 | Gastrointestinal infarctions (HP:0005244) | 2.06658272 |
113 | Hypercortisolism (HP:0001578) | 2.06063558 |
114 | Persistence of primary teeth (HP:0006335) | 2.03944691 |
115 | Cellulitis (HP:0100658) | 2.03569876 |
116 | Hyperventilation (HP:0002883) | 2.02921470 |
117 | Abnormality of the pericardium (HP:0001697) | 2.01669939 |
118 | Hemiplegia (HP:0002301) | 1.97565014 |
119 | Gaze-evoked nystagmus (HP:0000640) | 1.93518632 |
120 | Arthralgia (HP:0002829) | 1.92841822 |
121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92248122 |
122 | Petechiae (HP:0000967) | 1.91264267 |
123 | Generalized hypopigmentation (HP:0007513) | 1.90942471 |
124 | Abnormality of the neuromuscular junction (HP:0003398) | 1.89711800 |
125 | Fatigable weakness (HP:0003473) | 1.89711800 |
126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.89708424 |
127 | Osteomyelitis (HP:0002754) | 1.89345886 |
128 | Abnormal platelet function (HP:0011869) | 1.87491481 |
129 | Impaired platelet aggregation (HP:0003540) | 1.87491481 |
130 | Hypoproteinemia (HP:0003075) | 1.84143548 |
131 | Alopecia of scalp (HP:0002293) | 1.83840775 |
132 | Widely spaced teeth (HP:0000687) | 1.83774969 |
133 | Anorexia (HP:0002039) | 1.82206027 |
134 | Abnormality of dental color (HP:0011073) | 1.82081260 |
135 | Fair hair (HP:0002286) | 1.80805025 |
136 | Absent speech (HP:0001344) | 1.80318311 |
137 | Abnormality of the pleura (HP:0002103) | 1.80210390 |
138 | Attenuation of retinal blood vessels (HP:0007843) | 1.79666551 |
139 | Abnormality of the prostate (HP:0008775) | 1.78925807 |
140 | Urticaria (HP:0001025) | 1.78677600 |
141 | Papillary thyroid carcinoma (HP:0002895) | 1.76960609 |
142 | Abnormality of the renal cortex (HP:0011035) | 1.76851847 |
143 | Abnormality of the endocardium (HP:0004306) | 1.76353357 |
144 | Hypochromic anemia (HP:0001931) | 1.74921128 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.01564122 |
2 | FRK | 4.99003036 |
3 | JAK3 | 3.53626106 |
4 | ZAP70 | 3.37834924 |
5 | MAP4K1 | 3.34234457 |
6 | CLK1 | 3.28652892 |
7 | MAP3K14 | 3.10517879 |
8 | IRAK4 | 2.84040179 |
9 | KDR | 2.79017497 |
10 | IKBKE | 2.78415189 |
11 | TESK2 | 2.57389918 |
12 | TYK2 | 2.55844737 |
13 | JAK1 | 2.53877299 |
14 | TBK1 | 2.51786561 |
15 | BTK | 2.44519994 |
16 | MAP4K2 | 2.41641601 |
17 | AKT3 | 2.36636459 |
18 | FGFR4 | 2.30221419 |
19 | EPHA3 | 2.29733092 |
20 | TEC | 2.29633950 |
21 | BUB1 | 2.22211071 |
22 | NLK | 2.09047600 |
23 | ITK | 2.00104473 |
24 | PIK3CG | 1.77672061 |
25 | KIT | 1.67379955 |
26 | INSRR | 1.63772054 |
27 | IRAK3 | 1.61539698 |
28 | SRPK1 | 1.53922479 |
29 | EPHB1 | 1.52787688 |
30 | SYK | 1.51719041 |
31 | HCK | 1.44705495 |
32 | FGFR3 | 1.43326221 |
33 | LCK | 1.43277499 |
34 | MUSK | 1.41845601 |
35 | PRPF4B | 1.41379703 |
36 | BLK | 1.38712100 |
37 | NUAK1 | 1.35003178 |
38 | IKBKB | 1.34409459 |
39 | TGFBR1 | 1.29557219 |
40 | MAP3K12 | 1.24316861 |
41 | STK10 | 1.19413301 |
42 | IRAK1 | 1.15087594 |
43 | ERBB3 | 1.12175494 |
44 | ACVR1B | 1.10821151 |
45 | SGK2 | 1.10749062 |
46 | MAP3K2 | 1.08903529 |
47 | LRRK2 | 1.06501952 |
48 | TNK2 | 1.02291509 |
49 | PINK1 | 1.01090886 |
50 | PTK2B | 1.00289669 |
51 | SIK3 | 1.00218009 |
52 | LYN | 0.98998778 |
53 | TESK1 | 0.97846426 |
54 | PLK2 | 0.97419048 |
55 | MAP3K13 | 0.97320024 |
56 | FGR | 0.97201446 |
57 | RIPK4 | 0.94840317 |
58 | MST4 | 0.94458430 |
59 | PRKG2 | 0.91980152 |
60 | MAP3K3 | 0.89936720 |
61 | PIM1 | 0.89298398 |
62 | RPS6KA4 | 0.88753012 |
63 | JAK2 | 0.88052538 |
64 | MATK | 0.87816829 |
65 | BMPR1B | 0.87435318 |
66 | PRKCQ | 0.87075450 |
67 | CHUK | 0.84323931 |
68 | MAP2K6 | 0.83780599 |
69 | ERN1 | 0.83375481 |
70 | PIM2 | 0.80984306 |
71 | STK38L | 0.76338395 |
72 | MAPKAPK5 | 0.76092062 |
73 | MAPKAPK3 | 0.74359935 |
74 | NEK6 | 0.73280354 |
75 | TAOK3 | 0.72660378 |
76 | FER | 0.71754309 |
77 | FGFR2 | 0.71087874 |
78 | CAMKK2 | 0.70795730 |
79 | HIPK2 | 0.69639105 |
80 | TRPM7 | 0.69554953 |
81 | TIE1 | 0.67180724 |
82 | MAPK13 | 0.66971611 |
83 | PAK3 | 0.65739939 |
84 | TGFBR2 | 0.65702808 |
85 | SGK3 | 0.65403134 |
86 | EEF2K | 0.64740603 |
87 | EIF2AK3 | 0.63286391 |
88 | GRK6 | 0.62759643 |
89 | MYLK | 0.61817038 |
90 | STK24 | 0.59904925 |
91 | MARK3 | 0.59770874 |
92 | TSSK6 | 0.59648934 |
93 | ADRBK1 | 0.58786965 |
94 | DAPK2 | 0.57180125 |
95 | NEK9 | 0.55908752 |
96 | MAP3K1 | 0.54298591 |
97 | CSF1R | 0.53010135 |
98 | CSK | 0.52670097 |
99 | DYRK3 | 0.52580211 |
100 | OXSR1 | 0.52561830 |
101 | MAP3K4 | 0.51175050 |
102 | MAPK7 | 0.48279534 |
103 | PRKCH | 0.47750549 |
104 | LIMK1 | 0.47102247 |
105 | PDK1 | 0.46948076 |
106 | STK38 | 0.46574443 |
107 | STK3 | 0.44859810 |
108 | STK11 | 0.44662737 |
109 | IRAK2 | 0.43237347 |
110 | PRKCE | 0.42388568 |
111 | CAMK4 | 0.42109073 |
112 | CDK9 | 0.41375718 |
113 | LATS1 | 0.40764255 |
114 | GRK7 | 0.40473882 |
115 | ARAF | 0.39986673 |
116 | BMPR2 | 0.39816919 |
117 | IGF1R | 0.39602422 |
118 | STK4 | 0.38674164 |
119 | EGFR | 0.36760637 |
120 | ERBB2 | 0.36069380 |
121 | WNK3 | 0.34391616 |
122 | MAP2K3 | 0.33638352 |
123 | SGK494 | 0.33294412 |
124 | SGK223 | 0.33294412 |
125 | SRC | 0.32937909 |
126 | RPS6KA5 | 0.32016363 |
127 | PRKAA2 | 0.31461291 |
128 | ABL1 | 0.29158425 |
129 | DAPK3 | 0.29116670 |
130 | PDGFRB | 0.28848600 |
131 | RAF1 | 0.28484520 |
132 | FES | 0.28278703 |
133 | PRKCD | 0.28250539 |
134 | SCYL2 | 0.27435762 |
135 | MAPK15 | 0.26716691 |
136 | CDK6 | 0.26469660 |
137 | YES1 | 0.26269981 |
138 | FYN | 0.26201377 |
139 | CDK3 | 0.25812606 |
140 | ADRBK2 | 0.25343152 |
141 | INSR | 0.25047249 |
142 | RPS6KB2 | 0.19633481 |
143 | MAPKAPK2 | 0.19478236 |
144 | MAPK3 | 0.18940268 |
145 | SIK2 | 0.18697712 |
146 | BCKDK | 0.18472502 |
147 | FLT3 | 0.17574331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.37860337 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.08977328 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.92977825 |
4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.59166688 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.18858081 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 3.12648798 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.04081170 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.76738840 |
9 | Asthma_Homo sapiens_hsa05310 | 2.61238384 |
10 | Measles_Homo sapiens_hsa05162 | 2.49841769 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48404591 |
12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.46274252 |
13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.08196630 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06374196 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05884542 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94618538 |
17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.91265560 |
18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.77836278 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73594718 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.71257979 |
21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60718966 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56387953 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55162731 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39858816 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31366223 |
26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.30779651 |
27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29643902 |
28 | Malaria_Homo sapiens_hsa05144 | 1.25039621 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.19899759 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19848146 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19245452 |
32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19169898 |
33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15951829 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14105128 |
35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13816039 |
36 | Phagosome_Homo sapiens_hsa04145 | 1.13791027 |
37 | Legionellosis_Homo sapiens_hsa05134 | 1.11192606 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05933581 |
39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04355965 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.03668194 |
41 | Pertussis_Homo sapiens_hsa05133 | 0.98995079 |
42 | Shigellosis_Homo sapiens_hsa05131 | 0.95263036 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 0.94028199 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92148067 |
45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92032619 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 0.90233470 |
47 | Lysosome_Homo sapiens_hsa04142 | 0.89671411 |
48 | Phototransduction_Homo sapiens_hsa04744 | 0.87535756 |
49 | Renin secretion_Homo sapiens_hsa04924 | 0.86309604 |
50 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85459119 |
51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85376111 |
52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84764739 |
53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84326582 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84216613 |
55 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82708892 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82198000 |
57 | Platelet activation_Homo sapiens_hsa04611 | 0.81358882 |
58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80717167 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80654285 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79349202 |
61 | Salmonella infection_Homo sapiens_hsa05132 | 0.78402014 |
62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75670104 |
63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75517818 |
64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75404546 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73800174 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 0.73670575 |
67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71998776 |
68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71766698 |
69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70814487 |
70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69265272 |
71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68643795 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67549371 |
73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66285914 |
74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65069879 |
75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63654099 |
76 | Salivary secretion_Homo sapiens_hsa04970 | 0.63011483 |
77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60291663 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.59616811 |
79 | Ribosome_Homo sapiens_hsa03010 | 0.58154406 |
80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57439941 |
81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56940627 |
82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56316920 |
83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53935296 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.51776031 |
85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51219309 |
86 | Proteasome_Homo sapiens_hsa03050 | 0.50637669 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49312846 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48630151 |
89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48185785 |
90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47880374 |
91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47411963 |
92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46872435 |
93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46587261 |
94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45655590 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45123591 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44909092 |
97 | Prostate cancer_Homo sapiens_hsa05215 | 0.44694447 |
98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43931365 |
99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42872842 |
100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41498901 |
101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41185243 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40202361 |
103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40146015 |
104 | ABC transporters_Homo sapiens_hsa02010 | 0.40142337 |
105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39633788 |
106 | Long-term depression_Homo sapiens_hsa04730 | 0.38380355 |
107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36589273 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36327207 |
109 | Amoebiasis_Homo sapiens_hsa05146 | 0.36152581 |
110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36055206 |
111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35444178 |
112 | Base excision repair_Homo sapiens_hsa03410 | 0.35200210 |
113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32228061 |
114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31215012 |
115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30915485 |
116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27069237 |
117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26081718 |
118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25635537 |
119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23812988 |
120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23753882 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22671621 |
122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21724404 |
123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20354918 |
124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19560210 |
125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18252888 |
126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17781692 |
127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15417231 |
128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15366613 |
129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13427065 |
130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12386783 |
131 | Focal adhesion_Homo sapiens_hsa04510 | 0.12141844 |
132 | Adherens junction_Homo sapiens_hsa04520 | 0.11541070 |
133 | RNA degradation_Homo sapiens_hsa03018 | 0.10220756 |
134 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.09175359 |
135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07680413 |